Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feigenbaum

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates. 3. Comparative binding of dye-neuropeptide conjugates to FMRFamide receptors of Helix aspersa and Loligo pealeiJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Demography|September 20, 2022
Racial Disparities in Mortality During the 1918 Influenza Pandemic in United States CitiesMartin Eiermann, Elizabeth Wrigley-Field, James J Feigenbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blockerJ J Feigenbaum, F Bergmann, S A Richmond, et al.
Experientia|September 15, 1988
Enantiomeric cannabinoids: stereospecificity of psychotropic activityR Mechoulam, J J Feigenbaum, N Lander, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Biochemical and Biophysical Research Communications|October 23, 2010
MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutationBarbara S Connolly, Annette S J Feigenbaum, Brian H Robinson, et al.
Pediatric Neurology|June 13, 2009
Rolandic mitochondrial encephalomyelopathy and MT-ND3 mutationsKlaus G E Werner, Chantal F Morel, Adam Kirton, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates. 3. Comparative binding of dye-neuropeptide conjugates to FMRFamide receptors of Helix aspersa and Loligo pealeiJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Demography|September 20, 2022
Racial Disparities in Mortality During the 1918 Influenza Pandemic in United States CitiesMartin Eiermann, Elizabeth Wrigley-Field, James J Feigenbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blockerJ J Feigenbaum, F Bergmann, S A Richmond, et al.
Experientia|September 15, 1988
Enantiomeric cannabinoids: stereospecificity of psychotropic activityR Mechoulam, J J Feigenbaum, N Lander, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Biochemical and Biophysical Research Communications|October 23, 2010
MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutationBarbara S Connolly, Annette S J Feigenbaum, Brian H Robinson, et al.
Pediatric Neurology|June 13, 2009
Rolandic mitochondrial encephalomyelopathy and MT-ND3 mutationsKlaus G E Werner, Chantal F Morel, Adam Kirton, et al.
Pageof 7